Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Akero Therapeutics (AKRO – Research Report), Immunovant (IMVT – Research Report) and Teva Pharmaceutical (TEVA – Research Report). Akero Therapeutics (AKRO) Morgan Stanley analyst Matthew Harrison maintained a Hold rating on Akero Therapeutics today and set a price target of $40.00. The company's shares closed last Monday at $39.29, close to its 52-week high of $45.32. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-akero-therapeutics-akro-immunovant-imvt-and-teva-pharmaceutical-teva?utm_source=advfn.com&utm_medium=referral